10-K

Company

Celldex Therapeutics, Inc.

Filed

February 25, 2026

Period of Report

December 31, 2025

Accession Number

0001104659-26-019652

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →